9,055
Views
90
CrossRef citations to date
0
Altmetric
Review Articles

Extracellular vesicles: the growth as diagnostics and therapeutics; a survey

, ORCID Icon &
Article: 1438720 | Received 26 Jul 2017, Accepted 31 Jan 2018, Published online: 26 Feb 2018

References

  • Merchant ML, Rood IM, Deegens JK, et al. Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol. 2017. DOI:10.1038/nrneph.2017.148
  • Pap E, Falus A, Buzás EI. Membrane vesicles, current state‐of‐the‐ art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667‐88.
  • Simons M, Raposo G. Exosomes‐vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21(4):575‐81.
  • Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14(3):5338‐66.
  • Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581‐93.
  • Krebs MG, Hou J-M, Ward TH, et al. Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol. 2010;2(6):1–11.
  • Liga A, Vliegenthart AD, Oosthuyzen W, et al. Exosome isolation: a microfluidic road-map. Lab Chip. 2015;15(11):2388–2394.
  • Pugholm LH, Revenfeld ALS, Søndergaard EKL, et al. Antibody-based assays for phenotyping of extracellular vesicles. Biomed Res Int. 2015;2015:524817.
  • Yuana Y, Böing AN, Grootemaat AE, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. J Extracell Vesicles. 2015;4:29260.
  • Perakis S, Speicher MR. Emerging concepts in liquid biopsies. BMC Med. 2017;15:75.
  • Gold B, Cankovic M, Furtado LV, et al. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn. 2015;17(3):209–224.
  • 2016 Market research report by grand view research; liquid biopsy market size & forecast by application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) and trend analysis from 2013 – 2030. http://www.grandviewresearch.com/industry-analysis/liquid-biopsy-market
  • Munson P, Shukla A. Exosomes: potential in cancer diagnosis and therapy. Medicines (Basel). 2015;2(4):310–327.
  • Tcherpakov M. Exosome Diagnostics and Therapeutics: Global Markets. Wellesley, MA: BCC Research; 2016.
  • Alberts B, Johnson A, Lewis J, et al. Molecular biology of the cell. 4th. New York: Garland Science;2002. Helper T Cells and Lymphocyte Activation. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26827/
  • Scott AM, Allison JP, Wolchok JD. Monoclonal antibodies in cancer therapy. Cancer Immunity. 2012;12:14.
  • Chames P, Van Regenmortel M, Weiss E, et al. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol. 2009;157(2):220–233.
  • Weiner LM, Surana R, Wang S. Antibodies and cancer therapy: versatile platforms for cancer immunotherapy. Nat Reviews Immunol. 2010;10(5):317–327.
  • Kawikova I, Askenase PW. Diagnostic and therapeutic potentials of exosomes in CNS diseases. Brain Res. 2015 Aug 18;1617: 63–71. DOI:10.1016/j.brainres.2014.09.070.
  • Braccioli L, van Velthoven C, Heijnen CJ. Exosomes: a new weapon to treat the central nervous system. Mol Neurobiol. 2014 Feb;49(1):113–119. DOI:10.1007/s12035-013-8504-9.
  • Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J. 2016 Jun 1;14: 211–222. DOI:10.1016/j.csbj.2016.05.004.
  • Van Noorden R (2014, May 7). Global scientific output doubles every nine years. [cited 2017 Mar 01]. Available from: http://blogs.nature.com/news/2014/05/global-scientific-output-doubles-every-nine-years.htm
  • Igaz P. Circulating microRNAs in disease diagnostics and their potential biological relevance. 1. Basel (Switzerland): Springer; 2015. p. 46–49.
  • Naito Y, Yoshioka Y, Ochiya T. The functional role of exosomes in cancer biology and their potential as biomarkers and therapeutic targets of cancer. Gan To Kagaku Ryoho. 2015 Jun;42(6):647–655.
  • Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804.
  • Szatanek R, Baj-Krzyworzeka M, Zimoch J, et al. The methods of choice for Extracellular Vesicles (EVs) characterization. Int J Mol Sci. 2017;18(6):1153.
  • Koliha N, Wiencek Y, Heider U, et al. A novel multiplex bead-based platform highlights the diversity of extracellular vesicles. J Extracell Vesicles. 2016;5(1):29975.
  • Stevanato L, Thanabalasundaram L, Vysokov N, et al. Investigation of content, stoichiometry and transfer of miRNA from human neural stem cell line derived exosomes. Plos One. 2016;11(1). DOI:10.1371/journal.pone.0146353
  • Wen C, Seeger RC, Fabbri M, et al. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017;6(1):1400370.
  • Deun JV, Mestdagh P, Wever OD, et al. Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research. Cancer Res. 2017;77(13 Supplement). DOI:10.1158/1538-7445.am2017-lb-107
  • Kim D, Lee J, Simpson RJ, et al. EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin Cell Dev Biol. 2015;40:4–7.
  • Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10(12). DOI:10.1371/journal.pbio.1001450
  • Mathivanan S, Fahner CJ, Reid GE, et al. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2011;40(D1). DOI:10.1093/nar/gkr828